Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Progyny, a leader in fertility benefits management, announced participation in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 3:50 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny, a leader in fertility benefits management, announced participation in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 3:50 PM ET. CEO David Schlanger and CFO Mark Livingston will engage in a fireside chat, highlighting the company's innovative approach to family building benefits. A live audiocast will be accessible via the Events and Presentations section on Progyny's website. Progyny is recognized for redefining fertility solutions, benefiting patients and employers while driving clinical outcomes.
Details
News Market Reaction – PGNY
The recorded move for PGNY in the trading session of this news was +2.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 3:50 P.M. Eastern Time.
A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.